Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of William Panenka
Individual Investor

William Panenka

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Number of Exits 
    obfuscation
William Panenka is a founder and chief executive officer of Translational Life Sciences.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
William Panenka invested in Filament Health on
obfuscation
. This investment - Post-IPO Equity - Filament Health - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Filament Health Logo
Filament Health
—
Post-IPO Equity - Filament Health Logo
Post-IPO Equity - Filament Health
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
William Panenka has
obfuscation
exit - Filament Health. William Panenka has
obfuscation
exits. Their most notable exits are Filament Health.
  • Filament Health Logo
    Filament Health Filament Health is a natural psychedelic extraction and drug discovery company

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Jul 19, 2023
Filament Health raised
obfuscation
from Negev Capital and William Panenka
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|